ASX Stock of the Day: Austco Healthcare (ASX: AHC)
- futuregatecapital
- Feb 8
- 1 min read
FY24 Financial & Operational Highlights
Austco Healthcare (ASX: AHC) has delivered exceptional growth in FY24, reporting strong revenue expansion, a significant increase in profitability, and a robust cash position. The company’s strategy of organic growth and strategic acquisitions has positioned it for sustained success in the healthcare technology sector.
Financial Performance
FY24 Revenue: $58.15 million, reflecting a 38.53% YoY growth, driven by strong demand for healthcare communication solutions.
Net Profit After Tax (NPAT): $7.1 million, a 213% YoY increase, demonstrating enhanced profitability and cost efficiencies.
Revenue Forecast (1H FY25): Expected between $35.8M – $36.9M, a 59% YoY increase.
EBITDA Forecast (1H FY25): Expected between $4.5M – $5.1M, a 129% YoY increase.
Gross Profit Margins: Continued improvement, driven by operational efficiencies and product mix optimization.
Acquisitions Driving Growth
Austco Healthcare’s growth strategy combines organic expansion (~19% revenue growth and ~85% EBITDA growth YoY) with contributions from its recent acquisitions of Teknocorp (Nov 2023) and Amentco (May 2024).
Acquisition Contribution (1H FY25):
Revenue: $11.8M – $12.2M
EBITDA: $1.6M – $1.7M
These acquisitions have expanded market presence, enhanced service capabilities, and strengthened Austco Healthcare’s position in the industry.
Historically, second-half revenues and EBITDA are higher, indicating potential stronger full-year results.
Balance Sheet Strength & Liquidity
Cash on Hand: $13 million, ensuring a strong liquidity position for future growth.
Debt Position: No debt, providing financial flexibility and stability.
Market Capitalization: $91 million, reflecting a solid valuation in the healthcare technology sector
댓글